Origin Life Sciences Downsizes IPO
By Will Feuer Origin Life Sciences, a biotechnology company, downsized its planned initial public offering. The company now plans to offer 1.875 million...
Source: marketwatch.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Origin Life Sciences. Real-time updates on events, politics, business and more.